Strand Life Sciences and biotechnology startups in India

▴ strand-life-sciences-and-biotechnology-startups-in-india
India stands 12th in the world for its biotechnology startups. Should more funding be given to them to make India resilient against diseases like Covid-19?

Strand Life Sciences was founded in 2000 by Indian Institute of Sciences professors Vijay Chandru, Ramesh Hariharan, Swami Manohar, and V. Vinay. Their venture was initially registered as Strand Genomics. It primarily dealt with making software tools to assist biological data understanding. 

Later they renamed it Strand Life Sciences, a startup that makes personalised disease treatment from diabetes to cancer. This shift would help them earn 80% of its revenue by performing few diagnostic tests on rare diseases and cancer. They have worked with more than 200 scientists, engineers and pathologists in areas like oncology, fertility, genetics and more.

In 2004, Strand partnered with Agilent Technologies to work on their GeneSpring software and in 2010, they worked to make GeneSpring be useful in multiple life science disciplines. In 2007, the company turned profitable. 

In that same year, Strand Life Sciences had 30% of the global market which was valued at $200 million. The company has more than 1000 hospitals using its diagnostic tests including HCG, Max Hospitals Delhi, Apollo Hospitals, TMC Kolkata. They acquired Triesta Sciences, a healthcare global enterprise in 2018. It also acquired Quest Diagnostics, a leading provider of diagnostic information services. 

It has raised a total of $27.23 million in funding. The last funding round was in 2018, where Strand raised $12.43 million from Quadria Capital. Heritas Venture Fund and HealthQuad also participated in that round. In the same year, the company was valued at $50 million. Their operating revenues are between $100 - 500 crores as of 31st March 2020. 

The Bangalore startup is currently facing competition from NutraGene, MapMyGenome, XCode Life Sciences and more.

India stands 12th in the world for its biotechnology. Such Indian startups that provide better diagnosis, drug development and MedTech products only comprise 3% of the global biotech industry. With more biotechnology startups, India can master early disease diagnosis and prevention. It will help build a strong healthcare system where research is made available against future viruses and diseases. 

Should biotechnology startups get more funding to make India more resilient against diseases like Covid-19?

Tags : #StrandLifeSciences #biotechnology #biotech #startups #covid-19 #corporateupdate #smitakumar #medicircle

About the Author

Priyal Shah

Priyal Shah is a graduate of Media from Mithibai College, Mumbai. She is a writer, researcher and avid reader.

Related Stories

Loading Please wait...

Trending Now

PM addresses the Nation today, announces free vaccinesJune 07, 2021
Why inhalers are best for treating asthma, well illustrated by Dr. Anil SingalMay 12, 2021
Dr. Rohan Palshetkar shares his invaluable insights about the Maternal Mortality Rate causes and improvements in India April 29, 2021
It is important to adopt a non-judgmental attitude towards any teenage girl seeking contraceptive advise suggests Dr. Teena Trivedi, Obstetrician and GynecologistApril 16, 2021
80% of the diseases are psychosomatic which means they have roots in the mind and this is where homeopathy steps in - It resolves physical ailments by finding the cause in the mind – Dr. Sanket Dhuri, Consultant Homeopath April 14, 2021
A futuristic Vision of a Healthcare Entrepreneur: Shyatto Raha, CEO, and Founder of MyHealthcareApril 12, 2021
Saher Mehdi, Founder and Chief Scientist at wellOwise talks about aspects making healthcare more equitable and reachableApril 10, 2021
Wide variety of therapies to address autism in children explained by Dr. Shilpa Jasubhai, Clinical PsychologistApril 09, 2021
Allopathic and Homeopathic medicines should not be taken together says Dr. Sunil Mehra, Homeopath ConsultantApril 08, 2021
The charm of homeopathic medicine is that it can be taken with conventional medicines – Dr. Shruthi Shridhar, Consulting Homeopath April 08, 2021
Dissociative Identity Disorder and associated concepts explained by Dr. Vinod Kumar, Psychiatrist and Head of Mpower - The Centre (Bangalore) April 07, 2021
Dissociative Identity Disorder explained by Dr. Shilpa Jasubhai, Clinical PsychologistApril 05, 2021
Sehat Ki Baat, Karishma Ke Saath- Episode 6 Healthy Diet For Boosting Metabolism Which Can Help Thyroid Patients April 03, 2021
Significant Pointers on Kidney Health by Dr. Santosh Waigankar, Consultant Urooncologist and Robotic Surgeon at Kokilaben Dhirubhai Ambani HospitalApril 01, 2021
Dr. Vaishal Kenia, Ophthalmologist Talks About the Different Possibilities Available for the Treatment of Glaucoma Depending Upon Their Type and SeverityMarch 30, 2021
No Definitive Role of Diet in Treatment of Lymphedema but Intake of Calories, Salt and Long Chain Fatty Acids should be controlled says Dr. Ramani CVMarch 30, 2021
Dr. Kiran Chandra Patro, Senior Nephrologist Talks About Dialysis as the Temporary Process and Not a Permanent Cure for the Patients of Renal DysfunctionMarch 30, 2021
Two out of three new chronic kidney disease patients are found to have diabetes or hypertension informs Dr. Sreeharsha HarinathaMarch 30, 2021
Glaucoma Treatment: Medications or Surgery? A valuable piece of advice from Dr. Pranay Kapdia, Chairman and Medical Director of Kapadia Eye CareMarch 25, 2021
Dr. Shraddha Satav, Consultant Ophthalmologist Recommends that Everybody After 40, Should Go for the Complete Eye Checkup at Regular IntervalMarch 25, 2021